[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone

C105H107FN14O15 — CID 162258490

IUPAC[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone
SMILESCCc1cc(C(=O)N2CCC(c3ccc4c(c3)OCO4)C(O)C2)ccn1.Cn1ccn2ncc(C(=O)N3CCC(c4ccc5ccccc5c4)C(O)C3)c12.Cn1cncc1C(=O)N1CCC(c2ccc3ccccc3c2)C(O)C1.O=C(c1cccc(N2CCNC2=O)c1)N1CCC(c2ccc(F)cc2)C(O)C1.O=C(c1ccnc2ccccc12)N1CCC(c2ccc3c(c2)OCO3)C(O)C1
InChIInChI=1S/C22H22N4O2.C22H20N2O4.C21H22FN3O3.C20H21N3O2.C20H22N2O4/c1-24-10-11-26-21(24)19(13-23-26)22(28)25-9-8-18(20(27)14-25)17-7-6-15-4-2-3-5-16(15)12-17;25-19-12-24(22(26)17-7-9-23-18-4-2-1-3-16(17)18)10-8-15(19)14-5-6-20-21(11-14)28-13-27-20;22-16-6-4-14(5-7-16)18-8-10-24(13-19(18)26)20(27)15-2-1-3-17(12-15)25-11-9-23-21(25)28;1-22-13-21-11-18(22)20(25)23-9-8-17(19(24)12-23)16-7-6-14-4-2-3-5-15(14)10-16;1-2-15-9-14(5-7-21-15)20(24)22-8-6-16(17(23)11-22)13-3-4-18-19(10-13)26-12-25-18/h2-7,10-13,18,20,27H,8-9,14H2,1H3;1-7,9,11,15,19,25H,8,10,12-13H2;1-7,12,18-19,26H,8-11,13H2,(H,23,28);2-7,10-11,13,17,19,24H,8-9,12H2,1H3;3-5,7,9-10,16-17,23H,2,6,8,11-12H2,1H3
InChIKeyZYXKSGSZNMFTMU-UHFFFAOYSA-N
MW1824.09 g/mol
LogP13.04
Rot. Bonds12

About [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone

[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone (PubChem CID 162258490) has the molecular formula C105H107FN14O15 and a molecular weight of 1824.09 g/mol. Its IUPAC name is [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone.

Molecular Properties

Compound Name[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone
PubChem CID162258490
Molecular FormulaC105H107FN14O15
Molecular Weight1824.09 g/mol
Exact Mass1822.80
IUPAC Name[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone
SMILESCCc1cc(C(=O)N2CCC(c3ccc4c(c3)OCO4)C(O)C2)ccn1.Cn1ccn2ncc(C(=O)N3CCC(c4ccc5ccccc5c4)C(O)C3)c12.Cn1cncc1C(=O)N1CCC(c2ccc3ccccc3c2)C(O)C1.O=C(c1cccc(N2CCNC2=O)c1)N1CCC(c2ccc(F)cc2)C(O)C1.O=C(c1ccnc2ccccc12)N1CCC(c2ccc3c(c2)OCO3)C(O)C1
InChIInChI=1S/C22H22N4O2.C22H20N2O4.C21H22FN3O3.C20H21N3O2.C20H22N2O4/c1-24-10-11-26-21(24)19(13-23-26)22(28)25-9-8-18(20(27)14-25)17-7-6-15-4-2-3-5-16(15)12-17;25-19-12-24(22(26)17-7-9-23-18-4-2-1-3-16(17)18)10-8-15(19)14-5-6-20-21(11-14)28-13-27-20;22-16-6-4-14(5-7-16)18-8-10-24(13-19(18)26)20(27)15-2-1-3-17(12-15)25-11-9-23-21(25)28;1-22-13-21-11-18(22)20(25)23-9-8-17(19(24)12-23)16-7-6-14-4-2-3-5-15(14)10-16;1-2-15-9-14(5-7-21-15)20(24)22-8-6-16(17(23)11-22)13-3-4-18-19(10-13)26-12-25-18/h2-7,10-13,18,20,27H,8-9,14H2,1H3;1-7,9,11,15,19,25H,8,10,12-13H2;1-7,12,18-19,26H,8-11,13H2,(H,23,28);2-7,10-11,13,17,19,24H,8-9,12H2,1H3;3-5,7,9-10,16-17,23H,2,6,8,11-12H2,1H3
InChIKeyZYXKSGSZNMFTMU-UHFFFAOYSA-N
XLogP13.04
TPSA337.79 Ų
H-Bond Donors6
H-Bond Acceptors22
Rotatable Bonds12
Heavy Atoms135
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001824.09
LogP ≤ 513.04
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1022

Analyze [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone?
The IUPAC name of [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone (CID 162258490) is [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone.
What is the SMILES notation for [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone?
The canonical SMILES for [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone is CCc1cc(C(=O)N2CCC(c3ccc4c(c3)OCO4)C(O)C2)ccn1.Cn1ccn2ncc(C(=O)N3CCC(c4ccc5ccccc5c4)C(O)C3)c12.Cn1cncc1C(=O)N1CCC(c2ccc3ccccc3c2)C(O)C1.O=C(c1cccc(N2CCNC2=O)c1)N1CCC(c2ccc(F)cc2)C(O)C1.O=C(c1ccnc2ccccc12)N1CCC(c2ccc3c(c2)OCO3)C(O)C1.
What is the InChIKey of [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone?
The InChIKey is ZYXKSGSZNMFTMU-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H22N4O2.C22H20N2O4.C21H22FN3O3.C20H21N3O2.C20H22N2O4/c1-24-10-11-26-21(24)19(13-23-26)22(28)25-9-8-18(20(27)14-25)17-7-6-15-4-2-3-5-16(15)12-17;25-19-12-24(22(26)17-7-9-23-18-4-2-1-3-16(17)18)10-8-15(19)14-5-6-20-21(11-14)28-13-27-20;22-16-6-4-14(5-7-16)18-8-10-24(13-19(18)26)20(27)15-2-1-3-17(12-15)25-11-9-23-21(25)28;1-22-13-21-11-18(22)20(25)23-9-8-17(19(24)12-23)16-7-6-14-4-2-3-5-15(14)10-16;1-2-15-9-14(5-7-21-15)20(24)22-8-6-16(17(23)11-22)13-3-4-18-19(10-13)26-12-25-18/h2-7,10-13,18,20,27H,8-9,14H2,1H3;1-7,9,11,15,19,25H,8,10,12-13H2;1-7,12,18-19,26H,8-11,13H2,(H,23,28);2-7,10-11,13,17,19,24H,8-9,12H2,1H3;3-5,7,9-10,16-17,23H,2,6,8,11-12H2,1H3.
What are the key properties of [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone?
[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone has a molecular weight of 1824.09 g/mol, XLogP of 13.04, 12 rotatable bonds, 6 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for [4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-(2-ethyl-4-pyridinyl)methanone;[4-(1,3-benzodioxol-5-yl)-3-hydroxypiperidin-1-yl]-quinolin-4-ylmethanone;1-[3-[4-(4-fluorophenyl)-3-hydroxypiperidine-1-carbonyl]phenyl]imidazolidin-2-one;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(1-methylimidazo[2,1-e]pyrazol-7-yl)methanone;(3-hydroxy-4-naphthalen-2-ylpiperidin-1-yl)-(3-methylimidazol-4-yl)methanone is sourced from PubChem (CID 162258490), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).